Showing results (31-40 of 324) with videos related to
Sort By:
Pageof 33
Cancer Chemotherapy and Pharmacology|January 1, 1991
Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069)M Binger, P WorkmanBritish Journal of Cancer|August 1, 1995
Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipidsM Lohmeyer, P WorkmanClinical Oncology (Royal College of Radiologists (Great Britain))|November 22, 2001
Cardiac metastasis from a myxoid liposarcomaC Ng, J Stebbing, I JudsonJournal of Chromatography|December 22, 1993
High-performance liquid chromatographic assay for the measurement of the novel microtubule inhibitor 1069C85 in biological tissues and fluidsF Raynaud, M Walton, I JudsonAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2015
Titration of signalling output: insights into clinical combinations of MEK and AKT inhibitorsA Stewart, P Thavasu, J S de Bono, et al.International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Interaction of nitroimidazole sensitizers with drug metabolizing enzymes--spectral and kinetic studiesF Y Lee, P WorkmanInternational Journal of Cancer|January 2, 1994
Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activityJ A Plumb, P WorkmanBritish Journal of Cancer|May 1, 1993
In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434V G Brunton, P WorkmanInternational Journal of Radiation Oncology, Biology, Physics|August 1, 1984
Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069P Workman, M I WaltonInternational Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationshipsP Workman, P R TwentymanPageof 33